carbamates has been researched along with Glioma in 6 studies
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Excerpt | Relevance | Reference |
|---|---|---|
| " CDC20 expression is increased in a variety of tumors and associated with temozolomide (TMZ) resistance in glioma cells." | 8.02 | Apcin inhibits the growth and invasion of glioblastoma cells and improves glioma sensitivity to temozolomide. ( Ding, Y; He, L; Pan, Y; Song, X; Yu, S; Zhang, C; Zheng, C, 2021) |
| " CDC20 expression is increased in a variety of tumors and associated with temozolomide (TMZ) resistance in glioma cells." | 4.02 | Apcin inhibits the growth and invasion of glioblastoma cells and improves glioma sensitivity to temozolomide. ( Ding, Y; He, L; Pan, Y; Song, X; Yu, S; Zhang, C; Zheng, C, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Y | 1 |
| Zhang, C | 1 |
| He, L | 1 |
| Song, X | 1 |
| Zheng, C | 1 |
| Pan, Y | 1 |
| Yu, S | 1 |
| Piel, C | 1 |
| Pouchieu, C | 1 |
| Carles, C | 1 |
| Béziat, B | 1 |
| Boulanger, M | 1 |
| Bureau, M | 1 |
| Busson, A | 1 |
| Grüber, A | 1 |
| Lecluse, Y | 1 |
| Migault, L | 1 |
| Renier, M | 1 |
| Rondeau, V | 1 |
| Schwall, X | 1 |
| Tual, S | 1 |
| Pierre, L | 1 |
| Baldi, I | 1 |
| Kunschner, LJ | 1 |
| Fine, H | 1 |
| Hess, K | 1 |
| Jaeckle, K | 1 |
| Kyritsis, AP | 1 |
| Yung, WK | 1 |
| Murakami, D | 1 |
| Okamoto, I | 1 |
| Nagano, O | 1 |
| Kawano, Y | 1 |
| Tomita, T | 1 |
| Iwatsubo, T | 1 |
| De Strooper, B | 1 |
| Yumoto, E | 1 |
| Saya, H | 1 |
| Yang, DI | 1 |
| Yin, JH | 1 |
| Ju, TC | 1 |
| Chen, LS | 1 |
| Hsu, CY | 1 |
| Paylor, B | 1 |
| Holt, S | 1 |
| Fowler, CJ | 1 |
1 trial available for carbamates and Glioma
| Article | Year |
|---|---|
CI-980 for the treatment of recurrent or progressive malignant gliomas: national central nervous system consortium phase I-II evaluation of CI-980.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Carbamates; Disease-Free Survival; Female; Glio | 2002 |
5 other studies available for carbamates and Glioma
| Article | Year |
|---|---|
Apcin inhibits the growth and invasion of glioblastoma cells and improves glioma sensitivity to temozolomide.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Carbamates; Cell Line, Tumor; Cell Pr | 2021 |
Agricultural exposures to carbamate herbicides and fungicides and central nervous system tumour incidence in the cohort AGRICAN.
Topics: Adult; Aged; Agriculture; Animals; Carbamates; Carcinogens; Central Nervous System Neoplasms; Cohort | 2019 |
Presenilin-dependent gamma-secretase activity mediates the intramembranous cleavage of CD44.
Topics: Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Carbamates; Cell Membra | 2003 |
Nitric oxide and BCNU chemoresistance in C6 glioma cells: role of S-nitrosoglutathione.
Topics: Alkylation; Animals; Antineoplastic Agents, Alkylating; Antioxidants; Carbamates; Carmustine; Chelat | 2004 |
The potency of the fatty acid amide hydrolase inhibitor URB597 is dependent upon the assay pH.
Topics: Amidohydrolases; Animals; Benzamides; Brain; Brain Neoplasms; Carbamates; Enzyme Inhibitors; Ethanol | 2006 |